2023
DOI: 10.1016/j.mcpro.2022.100476
|View full text |Cite
|
Sign up to set email alerts
|

Proteins in Tumor-Derived Plasma Extracellular Vesicles Indicate Tumor Origin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 40 publications
0
6
0
Order By: Relevance
“…Recently, 14-3-3ε and α-actinin 4 have been identified in cancer-derived EVs in sera or plasma of cancer patients [61,62], while their extracellular oncogenic roles await thorough investigation. A related study reveals that human colorectal cancer cells release vesicles containing 14-3-3ξ along with β-catenin, which can be taken up by neighboring cells and enhance their migration ability via activation of the Wnt signaling [76].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Recently, 14-3-3ε and α-actinin 4 have been identified in cancer-derived EVs in sera or plasma of cancer patients [61,62], while their extracellular oncogenic roles await thorough investigation. A related study reveals that human colorectal cancer cells release vesicles containing 14-3-3ξ along with β-catenin, which can be taken up by neighboring cells and enhance their migration ability via activation of the Wnt signaling [76].…”
Section: Discussionmentioning
confidence: 99%
“…Despite lacking a signal sequence required for conventional protein secretion through the ER-to-Golgi route, 14-3-3ε and α-actinin 4 have been identified in the secretomes of various human cancer cell lines [59,60] and extracellular vesicles (EVs) originating from human cancers [61][62][63][64]. Moreover, 14-3-3ε and α-actinin 4 may be released directly from the cell membranes or liberated from the EVs to serve as ligands for cell-surface proteins.…”
Section: Introductionmentioning
confidence: 99%
“…Although NTA profiles indicate a significant increase in patients with FMA compared to controls, the use of EV quantification as a biomarker requires further research. Firstly, EVs can be increased in the cancer setting 31 , although evidence is conflicting 42 , and EVs in circulation come from a wide variety of origins, not just cancer, making them a heterogenous population of vesicles 43 . It is important to note that increased concentration of EVs may be due to a variety of reasons such as systemic inflammation, haematological diseases, or the presence of viruses, to name a few.…”
Section: Discussionmentioning
confidence: 99%
“…There is unfortunately no "perfect" method for EV isolation, but many methods are available (Serrano-Pertierra et al, 2019;Janouskova et al, 2022;Shirejini and Inci, 2022;Jalaludin et al, 2023). For our studies, we chose the ExoQuick and ME kits based on previous literature (Ricciardi et al, 2021;Aziz et al, 2022) and collaborator experience (Barlin et al, 2023). There was also research to show that the ME kit was successful for proteomic downstream processing (Ghosh et al, 2014;Knol et al, 2016;Askeland et al, 2020).…”
Section: Discussionmentioning
confidence: 99%